Creating Synthetic Patients to Address Interoperability Issues: A Case Study with the Management of Breast Cancer Patients.

Breast cancer Clinical decision support systems Health information interoperability Knowledge representation

Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
23 Nov 2020
Historique:
entrez: 23 11 2020
pubmed: 24 11 2020
medline: 26 11 2020
Statut: ppublish

Résumé

Interoperability issues are common in biomedical informatics. Reusing data generated from a system in another system, or integrating an existing clinical decision support system (CDSS) in a new organization is a complex task due to recurrent problems of concept mapping and alignment. The GL-DSS of the DESIREE project is a guideline-based CDSS to support the management of breast cancer patients. The knowledge base is formalized as an ontology and decision rules. OncoDoc is another CDSS applied to breast cancer management. The knowledge base is structured as a decision tree. OncoDoc has been routinely used by the multidisciplinary tumor board physicians of the Tenon Hospital (Paris, France) for three years leading to the resolution of 1,861 exploitable decisions. Because we were lacking patient data to assess the DESIREE GL-DSS, we investigated the option of reusing OncoDoc patient data. Taking into account that we have two CDSSs with two formalisms to represent clinical practice guidelines and two knowledge representation models, we had to face semantic and structural interoperability issues. This paper reports how we created 10,681 synthetic patients to solve these issues and make OncoDoc data re-usable by the GL-DSS of DESIREE.

Identifiants

pubmed: 33227764
pii: SHTI200718
doi: 10.3233/SHTI200718
doi:

Types de publication

Journal Article

Langues

eng

Pagination

177-181

Auteurs

Akram Redjdal (A)

Sorbonne Université, Université Sorbonne Paris Nord, INSERM, UMR S_1142, LIMICS, Paris, France.

Jacques Bouaud (J)

AP-HP, DRCI, Paris, France.
Sorbonne Université, Université Sorbonne Paris Nord, INSERM, UMR S_1142, LIMICS, Paris, France.

Gilles Guézennec (G)

Sorbonne Université, Université Sorbonne Paris Nord, INSERM, UMR S_1142, LIMICS, Paris, France.

Joseph Gligorov (J)

AP-HP, Hôpital Tenon, Paris, France.
Sorbonne Université, Institut Universitaire de Cancérologie, Paris, France.

Brigitte Seroussi (B)

Sorbonne Université, Université Sorbonne Paris Nord, INSERM, UMR S_1142, LIMICS, Paris, France.
AP-HP, Hôpital Tenon, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH